{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:36:03Z","timestamp":1790760963508,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"nhlbi\/smartt","award":["HHSN268201600011C"],"award-info":[{"award-number":["HHSN268201600011C"]}]},{"name":"nhlbi\/smartt","award":["HHSN268201600012C"],"award-info":[{"award-number":["HHSN268201600012C"]}]},{"name":"nhlbi\/smartt","award":["HHSN268201600014C"],"award-info":[{"award-number":["HHSN268201600014C"]}]},{"DOI":"10.13039\/100000001","name":"national science foundation","doi-asserted-by":"publisher","award":["CHE1904577"],"award-info":[{"award-number":["CHE1904577"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11307-021-01681-2","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T19:04:01Z","timestamp":1637089441000},"page":"479-488","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["First in Human Evaluation and Dosimetry Calculations for Peptide 124I-p5+14\u2014a Novel Radiotracer for the Detection of Systemic Amyloidosis Using PET\/CT Imaging"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5516-8578","authenticated-orcid":false,"given":"Jonathan S.","family":"Wall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily B.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Endsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan C.","family":"Stuckey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela D.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Whittle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler R.","family":"Lambeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan R.","family":"Julian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald H.","family":"Lands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Kennel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"1681_CR1","doi-asserted-by":"crossref","unstructured":"Muchtar E, Dispenzieri A, Magen H et al (2020) Systemic amyloidosis from A (AA) to T (ATTR): a review. J Intern Med.","DOI":"10.1111\/joim.13169"},{"key":"1681_CR2","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3324\/haematol.2013.102764","volume":"99","author":"JA Vrana","year":"2014","unstructured":"Vrana JA, Theis JD, Dasari S et al (2014) Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics. Haematologica 99:1239\u20131247","journal-title":"Haematologica"},{"key":"1681_CR3","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/j.mayocp.2020.06.029","volume":"95","author":"S Dasari","year":"2020","unstructured":"Dasari S, Theis JD, Vrana JA et al (2020) Amyloid typing by mass spectrometry in clinical practice: a comprehensive review of 16,175 samples. Mayo Clin Proc 95:1852\u20131864","journal-title":"Mayo Clin Proc"},{"key":"1681_CR4","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.jcmg.2020.02.025","volume":"13","author":"SAM Cuddy","year":"2020","unstructured":"Cuddy SAM, Bravo PE, Falk RH et al (2020) Improved quantification of cardiac amyloid burden in systemic light chain amyloidosis: redefining early disease? JACC Cardiovasc Imaging 13:1325\u20131336","journal-title":"JACC Cardiovasc Imaging"},{"key":"1681_CR5","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.jcmg.2019.07.015","volume":"13","author":"S Dorbala","year":"2020","unstructured":"Dorbala S, Cuddy S, Falk RH (2020) How to image cardiac amyloidosis: a practical approach. JACC Cardiovasc Imaging 13:1368\u20131383","journal-title":"JACC Cardiovasc Imaging"},{"key":"1681_CR6","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","volume":"26","author":"S Dorbala","year":"2019","unstructured":"Dorbala S, Ando Y, Bokhari S et al (2019) ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol 26:2065\u20132123","journal-title":"J Nucl Cardiol"},{"key":"1681_CR7","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.2967\/jnumed.118.221770","volume":"60","author":"EC Ehman","year":"2019","unstructured":"Ehman EC, El-Sady MS, Kijewski MF et al (2019) Early detection of multiorgan light-chain amyloidosis by whole-body (18)F-florbetapir PET\/CT. J Nucl Med 60:1234\u20131239","journal-title":"J Nucl Med"},{"key":"1681_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11886-020-01284-3","volume":"22","author":"C Gallegos","year":"2020","unstructured":"Gallegos C, Miller EJ (2020) Advances in PET-based cardiac amyloid radiotracers. Curr Cardiol Rep 22:40","journal-title":"Curr Cardiol Rep"},{"key":"1681_CR9","doi-asserted-by":"publisher","first-page":"7657","DOI":"10.3390\/molecules20057657","volume":"20","author":"JS Wall","year":"2015","unstructured":"Wall JS, Martin EB, Richey T et al (2015) Preclinical validation of the heparin-reactive peptide p5+14 as a molecular imaging agent for visceral amyloidosis. Molecules 20:7657\u20137682","journal-title":"Molecules"},{"key":"1681_CR10","doi-asserted-by":"publisher","first-page":"22695","DOI":"10.1038\/srep22695","volume":"6","author":"EB Martin","year":"2016","unstructured":"Martin EB, Williams A, Richey T et al (2016) Comparative evaluation of p5+14 with SAP and peptide p5 by dual-energy SPECT imaging of mice with AA amyloidosis. Sci Rep 6:22695","journal-title":"Sci Rep"},{"key":"1681_CR11","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1021\/ac100256v","volume":"82","author":"Q Sun","year":"2010","unstructured":"Sun Q, Yin S, Loo JA, Julian RR (2010) Radical directed dissociation for facile identification of iodotyrosine residues using electrospray ionization mass spectrometry. Anal Chem 82:3826\u20133833","journal-title":"Anal Chem"},{"key":"1681_CR12","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S0026-0495(98)90064-6","volume":"47","author":"PH Barrett","year":"1998","unstructured":"Barrett PH, Bell BM, Cobelli C et al (1998) SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies. Metabolism 47:484\u2013492","journal-title":"Metabolism"},{"key":"1681_CR13","first-page":"1023","volume":"46","author":"MG Stabin","year":"2005","unstructured":"Stabin MG, Sparks RB, Crowe E (2005) OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 46:1023\u20131027","journal-title":"J Nucl Med"},{"key":"1681_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/bmb\/ldt021","volume":"107","author":"S Sachchithanantham","year":"2013","unstructured":"Sachchithanantham S, Wechalekar AD (2013) Imaging in systemic amyloidosis. Br Med Bull 107:41\u201356","journal-title":"Br Med Bull"},{"key":"1681_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.carpath.2016.07.001","volume":"25","author":"MA Stats","year":"2016","unstructured":"Stats MA, Stone JR (2016) Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis. Cardiovasc Pathol 25:413\u2013417","journal-title":"Cardiovasc Pathol"},{"key":"1681_CR16","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","volume":"15","author":"DF Hutt","year":"2014","unstructured":"Hutt DF, Quigley AM, Page J et al (2014) Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. Eur Heart J Cardiovasc Imaging 15:1289\u20131298","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1681_CR17","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00259-018-3995-2","volume":"45","author":"T Wagner","year":"2018","unstructured":"Wagner T, Page J, Burniston M et al (2018) Extracardiac (18)F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds. Eur J Nucl Med Mol Imaging 45:1129\u20131138","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1681_CR18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1148\/rg.2017160074","volume":"37","author":"AV Chudgar","year":"2017","unstructured":"Chudgar AV, Shah JC (2017) Pictorial review of false-positive results on radioiodine scintigrams of patients with differentiated thyroid cancer. Radiographics 37:298\u2013315","journal-title":"Radiographics"},{"key":"1681_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.peptides.2014.07.024","volume":"60","author":"EB Martin","year":"2014","unstructured":"Martin EB, Kennel SJ, Richey T et al (2014) Dynamic PET and SPECT imaging with radioiodinated, amyloid-reactive peptide p5 in mice: a positive role for peptide dehalogenation. Peptides 60:63\u201370","journal-title":"Peptides"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-021-01681-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-021-01681-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-021-01681-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T16:30:29Z","timestamp":1652113829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-021-01681-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1681"],"URL":"https:\/\/doi.org\/10.1007\/s11307-021-01681-2","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,16]]},"assertion":[{"value":"12 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"EBM, TR, AS, and SJK are shareholders, and JSW is interim CSO, cofounder, and shareholder of Attralus Inc which licensed patents related to <sup>124<\/sup>I-p5+14 (AT-01). AE provides contracted drug development consulting support for Attralus Inc through Certara. JSW and SJK are inventors and have patent rights in peptide p5+14 for imaging amyloid.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}